Search Results - Prakash Varadarajan
- Showing 1 - 3 results of 3
-
1
-
2
Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma by J.L. Geiger, Julie E. Bauman, Michael K. Gibson, William E. Gooding, Prakash Varadarajan, Athanasios Κotsakis, Daniel Martı́n, J. Silvio Gutkind, Matthew L. Hedberg, Jennifer R. Grandis, Athanassios Argiris
Published 2016Artigo -
3
D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2 by An-Ping Lin, Saman Abbas, Sang‐Woo Kim, Manoela Marques Ortega, Hakim Bouamar, Yissela Escobedo, Prakash Varadarajan, Yuejuan Qin, Jessica Sudderth, Eduard Schulz, Alexander Deutsch, Sumitra Mohan, Peter Ulz, Peter Neumeister, Dinesh Rakheja, Xiaoli Gao, Andrew P. Hinck, Susan T. Weintraub, Ralph J. DeBerardinis, Heinz Sill, Patricia L. M. Dahia, Ricardo C.T. Aguiar
Published 2015Artigo
Search Tools:
Related Subjects
Alpha ketoglutarate
Basal cell
Biochemistry
Biology
Cell biology
Ectopic expression
Enzyme
Epigenetics
Everolimus
Gene
Head and neck
Head and neck cancer
Head and neck squamous-cell carcinoma
IDH1
IDH2
Internal medicine
Isocitrate dehydrogenase
Medicine
Metabolite
Mutant
Oncology
Radiation therapy
Surgery